4-(Dimethylamino)butylamine (CAS 3529-10-0)

4-(Dimethylamino)butylamine (CAS 3529-10-0) References

1. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.  |  Blanchard, S., et al. 2004. J Med Chem. 47: 978-87. PMID: 14761199
2. 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.  |  Allegretti, M., et al. 2005. J Med Chem. 48: 4312-31. PMID: 15974585
3. New quaternary ammonium oxicam derivatives: synthesis and in vitro antiosteoarthritis evaluation.  |  Vidal, A., et al. 2010. Eur J Med Chem. 45: 405-10. PMID: 19818539
4. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.  |  Palluotto, F., et al. 2016. Eur J Med Chem. 123: 704-717. PMID: 27521587
5. Letter: α,ω,N,N-Dimethylaminoalkylamines as possible derivatization agents for the analysis of small carbonyl compounds by low energy mass spectrometry.  |  Zhilyaev, DI., et al. 2016. Eur J Mass Spectrom (Chichester). 22: 151-8. PMID: 27553738
6. Antimicrobial Hybrid Coatings Combining Enhanced Biocidal Activity under Visible-Light Irradiation with Stimuli-Renewable Properties.  |  Manouras, T., et al. 2021. ACS Appl Mater Interfaces. 13: 17183-17195. PMID: 33734694
7. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.  |  Thompson, AM., et al. 1997. J Med Chem. 40: 3915-25. PMID: 9397172
8. Internal acid catalysis in the formation of imines from isobutyraldehyde and monoprotonated diamines  |  Jack Hine and Francis A. Via. 1977. J. Org. Chem., 42, 11,: 1972–1978.
9. Tyrosine Kinase Inhibitors. 14. Structure−Activity Relationships for Methyl- amino-Substituted Derivatives of 4-[(3-Bromophenyl)amino]-6-(methylamino)- pyrido[3,4-d]pyrimidine (PD 158780), a Potent and Specific Inhibitor of the Tyrosine Kinase Activity of Receptors for the EGF Family of Growth Factors  |  Gordon W. Rewcastle, Donna K. Murray, William L. Elliott, David W. Fry, Curtis T. Howard, James M. Nelson, Billy J. Roberts, Patrick W. Vincent, H. D. Hollis Showalter, R. Thomas Winters, and William A. Denny. 1998,. Med. Chem. 41, 5,: 742–751.
10. Overview of the synthetic routes of 2-alkyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamides-1,1-dioxides (oxicams) and their analogues  |  Moustafa A. Gouda. 2017 -. Synthetic Communications An International Journal for Rapid Communication of Synthetic Organic Chemistry. Volume 47, Issue 17: Pages 1527-1558.
11. Non-covalently crosslinked anion exchange membranes: Effect of urea hydrogen-bonding group position  |  H Wei, L Tong, S Yu, J Zhang, Y Dong, X Li, Y Ding - Polymer, 2019 - Elsevier. 28 September 2019,. Polymer. Volume 179,: 121654.
12. Synthesis and medicinal importance of oxicams and their analogues  |  Moustafa A. Gouda, et al. Pages 1709-1736. Synthetic Communications An International Journal for Rapid Communication of Synthetic Organic Chemistry,. Volume 47: 2017 - Issue 19.